Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta(c)quinolin-8-yl)ethanone
2. G-1 Cpd
1. Gpr30 Agonist, G-1
2. G-1
3. 881639-98-1
4. Lns8801
5. Lns-8801
6. Tfs4qe36zg
7. Y3v5bv7okm
8. G 1 (anti-tumor Agent)
9. Chembl569766
10. 1-[(3as,4r,9br)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta[c]quinolin-8-yl]ethanone
11. G1
12. 925419-53-0
13. Ethanone, 1-((3as,4r,9br)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta(c)quinolin-8-yl)-
14. G-1 Cpd
15. Sr-01000506928
16. Gper Agonist
17. Unii-tfs4qe36zg
18. Unii-y3v5bv7okm
19. G 1 (gper Agonist)
20. Gtpl1014
21. Schembl12700948
22. Cid_3136849
23. Cid_5322399
24. Chebi:156296
25. Hms3414a07
26. Hms3650i22
27. Hms3678a07
28. Ml051
29. Ex-a3642
30. Zinc4172149
31. Bdbm50303803
32. Stk330808
33. Akos015969580
34. 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta(c)quinolin-8-yl)ethanone
35. Hy-107216
36. Cs-0027669
37. Unm000000675701
38. Unm000011063001
39. Sr-01000506928-1
40. Sr-01000506928-3
41. Q27077759
42. G 1 (g Protein-coupled Estrogen Receptor Agonist)
43. (+/-)-1-[(3ar*,4s*,9bs*)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta[c]quinolin-8-yl]- Ethanone
44. 1-((3as,4r,9br)-4-(6-bromobenzo[d][1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta[c]quinolin-8-yl)ethanone
45. 1-[4-(6-bromo-benzo[1,3]dioxol-5-yl)-3-alpha-4,5,9-beta-tetrahydro-3h-cyclopenta[c]quinolin-8-yl]-ethanone
46. Ethanone, 1-((3ar,4s,9bs)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta(c)quinolin-8-yl)-, Rel-
Molecular Weight | 412.3 g/mol |
---|---|
Molecular Formula | C21H18BrNO3 |
XLogP3 | 4.6 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 2 |
Exact Mass | 411.04701 g/mol |
Monoisotopic Mass | 411.04701 g/mol |
Topological Polar Surface Area | 47.6 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 596 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
84
PharmaCompass offers a list of LNS8801 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right LNS8801 manufacturer or LNS8801 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred LNS8801 manufacturer or LNS8801 supplier.
PharmaCompass also assists you with knowing the LNS8801 API Price utilized in the formulation of products. LNS8801 API Price is not always fixed or binding as the LNS8801 Price is obtained through a variety of data sources. The LNS8801 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A LNS8801 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LNS8801, including repackagers and relabelers. The FDA regulates LNS8801 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LNS8801 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A LNS8801 supplier is an individual or a company that provides LNS8801 active pharmaceutical ingredient (API) or LNS8801 finished formulations upon request. The LNS8801 suppliers may include LNS8801 API manufacturers, exporters, distributors and traders.
LNS8801 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of LNS8801 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right LNS8801 GMP manufacturer or LNS8801 GMP API supplier for your needs.
A LNS8801 CoA (Certificate of Analysis) is a formal document that attests to LNS8801's compliance with LNS8801 specifications and serves as a tool for batch-level quality control.
LNS8801 CoA mostly includes findings from lab analyses of a specific batch. For each LNS8801 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
LNS8801 may be tested according to a variety of international standards, such as European Pharmacopoeia (LNS8801 EP), LNS8801 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (LNS8801 USP).